Target intelligence / Profile preview

Troponin C, fast skeletal muscle (TNNC2)

Target
TNNC2
Molecular classification
Cytoskeletal protein, Calcium sensor, Structural protein
01

Overview

Troponin C, fast skeletal muscle (TNNC2), is the calcium-binding component of the troponin complex specific to fast-twitch skeletal muscle fibers[2][3][4]. It functions as the primary **calcium sensor** that regulates striated muscle contraction by binding Ca2+ and transmitting conformational changes that relieve inhibition of actin-myosin interaction[1][2][5]. TNNC2 is composed of four EF-hand domains, of which two N-terminal sites are regulatory (binding Ca2+) and two C-terminal sites are structural (often binding Mg2+ in the resting state)[1]. Upon calcium binding, TNNC2 promotes the displacement of tropomyosin on actin filaments, allowing myosin head attachment and muscle contraction[1][2]. Pathogenic variants can cause rare congenital myopathies, but TNNC2 is most widely recognized for its essential physiological role in rapid skeletal muscle force generation[3][4]. While the fast skeletal isoform is not a routine therapeutic target, its homologs in cardiac tissue (cardiac troponin C) are key clinical biomarkers and drug targets[1]. Drugs such as bepridil interact with troponin C to sensitize Ca2+ binding in cardiac muscle, and similar approaches have been proposed for skeletal isoforms but remain experimental[1]. The troponin C, fast skeletal muscle gene is found on chromosome 20 in humans[3][4].

Other names
Troponin C2, fast skeletal typeTNNC2Troponin C, skeletal muscleFAP85CFAP85CMYO15CMYP15MYONRI
02

Mechanism of action

Calcium sensitization (stabilizing Ca2+-bound conformation to enhance muscle contraction); Modulation of troponin complex activity on the thin filament

03

Biological functions

Regulation of skeletal muscle contractionCalcium bindingControl of actin-myosin interactionSignal transduction in muscle contraction
04

Disease associations

Congenital myopathies (rare variants)Muscle contractile disordersPotential implication in muscle pathologyOther
05

Safety considerations

Limited druggability due to isoform specificityPotential off-target effects in muscle tissueSafety concerns extrapolated from cardiac isoforms
06

Interacting drugs

Bepridil (interacts with TnC isoforms)

1 more in the full profile.

07

Biomarkers

Circulating troponin C isoforms (mostly cardiac isoform, but skeletal may have relevance in muscle damage)Not routinely used as a clinical biomarker

Beyond the preview

Go deeper on Troponin C, fast skeletal muscle (TNNC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Troponin C, fast skeletal muscle (TNNC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call